- Experience. Each year, Mayo Clinic doctors diagnose and treat thousands of people with pulmonary hypertension, including people with rare, complex and chronic conditions. Mayo surgeons have extensive experience in pulmonary-hypertension-related heart surgery.
- Research leader. Mayo Clinic researchers have been involved in clinical studies of treatment approaches for pulmonary hypertension for years. You may be eligible to participate in a trial of a new treatment, including clinical trials conducted at Mayo Clinic.
Related book: Mayo Clinic Healthy Heart for Life! book provides an easy-to-follow plan to prevent and conquer heart disease.
Mayo Clinic in Rochester, Minn., is ranked among the Best Hospitals for heart and heart surgery by U.S. News & World Report. Mayo Clinic also ranks among the Best Children's Hospitals for heart and heart surgery.
Mayo Clinic: Answers you can trust
At Mayo Clinic, we assemble a team of specialists who take the time to listen and thoroughly understand your health issues and concerns. We tailor the care you receive to your personal health care needs. You can trust our specialists to collaborate and offer you the best possible outcomes, safety and service.
Mayo Clinic is a not-for-profit medical institution that reinvests all earnings into improving medical practice, research and education. We're constantly involved in innovation and medical research, finding solutions to improve your care and quality of life. Your doctor or someone on your medical team is likely involved in research related to your condition.
Our patients tell us that the quality of their interactions, our attention to detail and the efficiency of their visits mean health care — and trusted answers — like they've never experienced.
Why Choose Mayo Clinic
What Sets Mayo Clinic Apart
March 27, 2013
- McLaughlin VV, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension. Journal of the American College of Cardiology. 2009;53:1573.
- Pulmonary hypertension. American Heart Association. http://www.heart.org/HEARTORG/Conditions/CongenitalHeartDefects/TheImpactofCongenitalHeartDefects/Pulmonary-Hypertension_UCM_307044_Article.jsp. Accessed Jan. 25, 2012.
- Pulmonary arterial hypertension. Genetics Home Reference. http://ghr.nlm.nih.gov/condition=pulmonaryarterialhypertension. Accessed Jan. 25, 2012.
- Austin ED, et al. Genetics and mediators in pulmonary arterial hypertension. Clinical Chest Medicine. 2007;28:43.
- Connolly HM, et al. Evaluation and prognosis of Eisenmenger syndrome. http://www.uptodate.com/index. Accessed Jan. 25, 2012.
- Badesch DB, et al. Diagnosis and assessment of pulmonary hypertension. Journal of the American College of Cardiology. 2009;54:S55.
- Simonneau G, et al. Updated clinical classification of pulmonary hypertension. Journal of the American College of Cardiology. 2009;54:S43.
- Badesch DB, et al. Medical therapy for pulmonary arterial hypertension: Updated ACCP evidence-based clinical practice guidelines. Chest. 2007;131:1917.
- Keogh AM, et al. Interventional and surgical modalities of treatment in pulmonary hypertension. Journal of the American College of Cardiology. 2009;54:S67.
- Galie N, et al. Tadalafil therapy for pulmonary arterial hypertension. Circulation. 2009;119:2894.
- Letairis (prescribing information). Foster City, Calif.: Gilead Sciences, Inc.; 2011. http://www.letairis.com/patients/fpi.asp. Accessed Jan. 25, 2012.
- Rubin LJ, et al. Diagnostic evaluation of pulmonary hypertension. http://www.uptodate.com/index. Accessed Jan. 25, 2012.
- McGoon MD, et al. Pulmonary arterial hypertension: Diagnosis and management. Mayo Clinic Proceedings. 2009;84:191.
- Fuster V, ed., et al. Hurst's The Heart. 13th ed. New York, N.Y.: The McGraw-Hill Companies; 2011. http://www.accessmedicine.com/resourceTOC.aspx?resourceID=5. Accessed Feb. 3, 2012.